102 related articles for article (PubMed ID: 19150065)
1. Identification of the target for therapeutic recombinant anti-apoB-100 peptide antibodies in human atherosclerotic lesions.
Gonçalves I; Nitulescu M; Ares MP; Fredrikson GN; Jansson B; Li ZC; Nilsson J
Atherosclerosis; 2009 Jul; 205(1):96-100. PubMed ID: 19150065
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of injury-induced arterial remodelling and carotid atherosclerosis by recombinant human antibodies against aldehyde-modified apoB-100.
Ström A; Fredrikson GN; Schiopu A; Ljungcrantz I; Söderberg I; Jansson B; Carlsson R; Hultgårdh-Nilsson A; Nilsson J
Atherosclerosis; 2007 Feb; 190(2):298-305. PubMed ID: 16677655
[TBL] [Abstract][Full Text] [Related]
3. Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice.
Schiopu A; Frendéus B; Jansson B; Söderberg I; Ljungcrantz I; Araya Z; Shah PK; Carlsson R; Nilsson J; Fredrikson GN
J Am Coll Cardiol; 2007 Dec; 50(24):2313-8. PubMed ID: 18068040
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis.
Schiopu A; Bengtsson J; Söderberg I; Janciauskiene S; Lindgren S; Ares MP; Shah PK; Carlsson R; Nilsson J; Fredrikson GN
Circulation; 2004 Oct; 110(14):2047-52. PubMed ID: 15451805
[TBL] [Abstract][Full Text] [Related]
5. Circulating autoantibodies against the apolipoprotein B-100 peptides p45 and p210 in relation to the occurrence of carotid plaques in 64-year-old women.
Fagerberg B; Prahl Gullberg U; Alm R; Nilsson J; Fredrikson GN
PLoS One; 2015; 10(3):e0120744. PubMed ID: 25768285
[TBL] [Abstract][Full Text] [Related]
6. Humoral immune response against defined oxidized low-density lipoprotein antigens reflects structure and disease activity of carotid plaques.
Gonçalves I; Gronholdt ML; Söderberg I; Ares MP; Nordestgaard BG; Bentzon JF; Fredrikson GN; Nilsson J
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1250-5. PubMed ID: 15831809
[TBL] [Abstract][Full Text] [Related]
7. Low levels of IgG autoantibodies against the apolipoprotein B antigen p210 increases the risk of cardiovascular death after carotid endarterectomy.
Asciutto G; Dias NV; Edsfeldt A; Alm R; Fredrikson GN; Gonçalves I; Nilsson J
Atherosclerosis; 2015 Apr; 239(2):289-94. PubMed ID: 25682025
[TBL] [Abstract][Full Text] [Related]
8. Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease.
Fredrikson GN; Hedblad B; Berglund G; Alm R; Ares M; Cercek B; Chyu KY; Shah PK; Nilsson J
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):872-8. PubMed ID: 12649091
[TBL] [Abstract][Full Text] [Related]
9. Impact of multiple antigenic epitopes from ApoB100, hHSP60 and Chlamydophila pneumoniae on atherosclerotic lesion development in Apob(tm2Sgy)Ldlr(tm1Her)J mice.
Lu X; Xia M; Endresz V; Faludi I; Szabo A; Gonczol E; Mundkur L; Chen D; Kakkar V
Atherosclerosis; 2012 Nov; 225(1):56-68. PubMed ID: 22959702
[TBL] [Abstract][Full Text] [Related]
10. Immunization with a combination of ApoB and HSP60 epitopes significantly reduces early atherosclerotic lesion in Apobtm2SgyLdlrtm1Her/J mice.
Lu X; Chen D; Endresz V; Xia M; Faludi I; Burian K; Szabo A; Csanadi A; Miczak A; Gonczol E; Kakkar V
Atherosclerosis; 2010 Oct; 212(2):472-80. PubMed ID: 20609438
[TBL] [Abstract][Full Text] [Related]
11. Induction of T helper 2 responses against human apolipoprotein B100 does not affect atherosclerosis in ApoE-/- mice.
Engelbertsen D; Rattik S; Knutsson A; Björkbacka H; Bengtsson E; Nilsson J
Cardiovasc Res; 2014 Jul; 103(2):304-12. PubMed ID: 24866382
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein B-100 Antibody Interaction With Atherosclerotic Plaque Inflammation and Repair Processes.
Asciutto G; Wigren M; Fredrikson GN; Mattisson IY; Grönberg C; Alm R; Björkbacka H; Dias NV; Edsfeldt A; Gonçalves I; Nilsson J
Stroke; 2016 Apr; 47(4):1140-3. PubMed ID: 26965851
[TBL] [Abstract][Full Text] [Related]
13. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice.
Zhou X; Paulsson G; Stemme S; Hansson GK
J Clin Invest; 1998 Apr; 101(8):1717-25. PubMed ID: 9541503
[TBL] [Abstract][Full Text] [Related]
14. Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis.
Gisterå A; Hermansson A; Strodthoff D; Klement ML; Hedin U; Fredrikson GN; Nilsson J; Hansson GK; Ketelhuth DF
J Intern Med; 2017 Apr; 281(4):383-397. PubMed ID: 28194913
[TBL] [Abstract][Full Text] [Related]
15. High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction.
Sjögren P; Fredrikson GN; Samnegard A; Ericsson CG; Ohrvik J; Fisher RM; Nilsson J; Hamsten A
Eur Heart J; 2008 Sep; 29(18):2218-26. PubMed ID: 18664466
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune responses against the apo B-100 LDL receptor-binding site protect against arterial accumulation of lipids in LDL receptor deficient mice.
Fredrikson GN; Lindholm MW; Ljungcrantz I; Söderberg I; Shah PK; Nilsson J
Autoimmunity; 2007 Mar; 40(2):122-30. PubMed ID: 17453711
[TBL] [Abstract][Full Text] [Related]
17. Plasma autoantibodies against apolipoprotein B-100 peptide 210 in subclinical atherosclerosis.
McLeod O; Silveira A; Fredrikson GN; Gertow K; Baldassarre D; Veglia F; Sennblad B; Strawbridge RJ; Larsson M; Leander K; Gigante B; Kauhanen J; Rauramaa R; Smit AJ; Mannarino E; Giral P; Humphries SE; Tremoli E; de Faire U; Ohrvik J; Nilsson J; Hamsten A
Atherosclerosis; 2014 Jan; 232(1):242-8. PubMed ID: 24401246
[TBL] [Abstract][Full Text] [Related]
18. Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression.
Tsimikas S; Aikawa M; Miller FJ; Miller ER; Torzewski M; Lentz SR; Bergmark C; Heistad DD; Libby P; Witztum JL
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):175-81. PubMed ID: 17082490
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences.
Fredrikson GN; Söderberg I; Lindholm M; Dimayuga P; Chyu KY; Shah PK; Nilsson J
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):879-84. PubMed ID: 12649092
[TBL] [Abstract][Full Text] [Related]
20. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.
Tsimikas S; Witztum JL; Miller ER; Sasiela WJ; Szarek M; Olsson AG; Schwartz GG;
Circulation; 2004 Sep; 110(11):1406-12. PubMed ID: 15353498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
